期刊文献+

磷酸化蛋白EBP50通过降低ERK1/2活性抑制乳腺癌细胞MCF-7增殖能力 被引量:7

Phosphoprotein EBP50 suppresses proliferation of breast cancer by inhibiting activity of ERK1/2 in MCF-7 cell line
下载PDF
导出
摘要 目的探讨磷酸化蛋白EBP50对乳腺癌细胞MCF-7细胞增殖的影响及其潜在机制研究。方法使用p GPU6/Neo载体构建稳定敲除EBP50表达的MCF-7细胞株,使用Western blot检测乳腺癌细胞中EBP50、c-myc、p-ERK1/2以及ERK1/2的表达,使用磺酰罗丹明B染色方法检测乳腺癌细胞增殖。结果使用p GPU6/Neo载体可以稳定地降低MCF-7细胞中EBP50的表达,敲除EBP50可以促进乳腺癌细胞增殖,同时促进c-myc的表达,上调ERK1/2的磷酸化水平,但不影响ERK1/2的表达。结论 EBP50可以通过抑制ERK1/2活性,抑制MCF-7乳腺癌细胞增殖能力。 Aim To investigate the relationship be-tween phosphoprotein EBP50 and the proliferation of breast cancer in MCF-7 cells. Methods The quali-fied recombinant plasmid sh-EBP50-pGPU6/Neo was transfected into MCF-7 cells with EBP50 knocking down. The expression of EBP50, c-myc, p-ERK1/2, and ERK1/2 was detected by Western blot. The prolif-eration ability of cells was detected by sulforhodamine B assay. Results The EBP50 knocking down plasmid was constructed successfully. MCF-7 cells with EBP50 knocking down had been established successfully. Knocking down of EBP50 increased the proliferation of MCF-7 significantly, and partially augmented the ex-pression of c-myc and phosphorylation of ERK1/2 . However, knocking down of EBP50 did not impact the expression of ERK1/2 . Conclusion EBP50 suppres-ses the proliferation of breast cancer cell through inhib-iting the activity of ERK1/2 in MCF-7 cell line.
出处 《中国药理学通报》 CAS CSCD 北大核心 2015年第1期55-59,共5页 Chinese Pharmacological Bulletin
基金 国家科技部"重大新药创制"科技重大专项(No2012ZX09301002-01) 国家自然科学基金资助项目(No31401186) 中央级公益性科研院所基本科研业务专项(No IMBF201407)
关键词 EBP50 ERK1/2 MCF-7 乳腺癌 增殖 pGPU6/Neo pGPU6/Neo breast canc-er proliferation pGPU6/Neo
  • 相关文献

参考文献2

二级参考文献2

共引文献9

同被引文献81

  • 1姚华,林德贵,田克恭,遇秀玲,胡冬梅.犬乳腺肿物临床病案分析[J].中国兽医杂志,2006,42(7):50-51. 被引量:15
  • 2James A. McCubrey,Linda S. Steelman,William H. Chappell,Stephen L. Abrams,Ellis W.T. Wong,Fumin Chang,Brian Lehmann,David M. Terrian,Michele Milella,Agostino Tafuri,Franca Stivala,Massimo Libra,Jorg Basecke,Camilla Evangelisti,Alberto M. Martelli,Richard A. Franklin.Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance[J]. BBA - Molecular Cell Research . 2006 (8)
  • 3James M. Chen,Regina Monaco,Spero Manolatos,Paul W. Brandt-Rauf,Fred K. Friedman,Matthew R. Pincus.Molecular Dynamics on Complexes of ras-p21 and Its Inhibitor Protein, rap-1A, Bound to the ras-Binding Domain of the raf-p74 Protein: Identification of Effector Domains in the raf Protein[J]. Journal of Protein Chemistry . 1997 (6)
  • 4Wu X,Hepner K,Castelino-Prabhu S,et al.Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proceedings of the National Academy of Sciences of the United States of America . 2000
  • 5Aradhana Awasthi,Asanga Samarakoon,Haiyan Chu.Rap1b facilitates NK cell functions via IQGAP1-mediated signalosomes. The Journal of Experimental Medicine . 2010
  • 6Jing Li,Ying Fan,Yi-Na Zhang.The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine. Pharmazie . 2012
  • 7黄陈招(综述),朱彩凤(审校),朱斌(审校).MAPK信号转导通路与肾纤维化[J].国际泌尿系统杂志,2008,28(6):829-833. 被引量:5
  • 8李东,姜淼.中药白毛夏枯草水提液体外抗肿瘤研究[J].吉林中医药,2009,29(5):434-435. 被引量:20
  • 9卢雯平,姜翠红.古方治疗乳腺癌的用药规律[J].中国实验方剂学杂志,2010,16(3):133-134. 被引量:24
  • 10吴向华,陆云飞,黄名威.ERK及JNK/MAPK通路在复发转移乳腺癌中的表达及临床意义[J].广东医学,2010,31(14):1841-1843. 被引量:9

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部